Apimeds
APUS
Apimeds (APUS) news
Recent news
Apimeds Pharmaceuticals US - receives 100% Korean clinic rights, 25% U.S. royalty, 25% overseas revenue participation for Apitox - SEC filing
AInvest Wire · Aug 21, 2026Apimeds Pharmaceuticals US - enters assignment and transfer agreement with Freet on Aug 19, 2026 - SEC filing
AInvest Wire · Aug 21, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.